As the largest imaging core lab, Bioclinica brings over 28 years of clinical trial experience and medical image review to your Metabolic/Endocrinology study. Our dedicated teams of therapeutic specialists provide targeted expertise and quality results.
Bioclinica has conducted over 65 drug studies covering all major indications for metabolic and endocrinology diseases including diabetes and obesity. We have experience with all trial phases and can provide support from the start of a trial (protocol design and imaging charter development) all the way through to regulatory submission and archiving of image data (with a full 21 CFR Part 11 compliant process). We have extensive experience with imaging for Eligibility (inclusion or exclusion of study patients), Efficacy (primary and secondary endpoints), and Safety (evaluating cardiovascular and bone safety profiles) components of clinical trials.
Bioclinica has experience supporting trials for the following indications:
|Acid Sphingomyelinase Deficiency|
|Benign Prostatic Hyperplasia|
|Congenital Adrenal Hyperplasia|
|Growth Hormone Deficiency|
|McCune Albright Syndrome|
|Primary Sclerosing Cholangitis|